These compounds may interact with:
Metabotropic glutamate receptor 1
Potentially involved in: neurodegenerative disease; kidney cancer; carcinoma; epilepsy; schizophrenia; melanoma; cerebellar ataxia; fragile x syndrome; toxic encephalopathy; alcoholic intoxication, chronic; blepharoptosis; mental depression; depressive disorder; dysarthria; epilepsy, temporal lobe; esotropia; fibroma; flatfoot; mental retardation; muscle hypotonia
Disease data sourced from Pharos.